placeholder image
L. M. McEwen All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Novel method for predicting Lp(a) from genomic testing identifies ASCVD risk across a diverse cohort. 
    JACC. Basic to translational science. 2025
  • XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants. 
    Frontiers in Immunology. 2025
  • Reduced likelihood of hospitalization with the JN.1 or HV.1 severe acute respiratory syndrome coronavirus 2 variants compared with the EG.5 variant. 
    Journal of Infectious Diseases. 2024
  • SARS-CoV-2 antiviral prescribing gaps among non-hospitalized high-risk adults. 
    Clinical Infectious Diseases. 2024
  • Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes. 
    Commun Med (Lond). 2024
    • Contact
    full name
  • L. M. McEwen
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration